Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 12 | 20 | 1998 | 2019 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
disease | 1.000 | None | 0.942 | 3 | 2 | 1992 | 2019 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
disease | 1.000 | strong | 0.980 | 2 | 2 | 1988 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 1.000 | None | 0.967 | 1 | 1 | 1983 | 2020 | ||||||||
|
huntingtin | 0.548 | 0.654 | 1.00 |
|
disease | 1.000 | limited | 0.987 | 1 | 17 | 1993 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 1.000 | definitive | 0.984 | 1 | 1 | 1995 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 1.000 | strong | 0.951 | 1 | 1 | 1994 | 2020 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.900 | strong | 0.943 | 11 | 3 | 1996 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.900 | None | 0.945 | 4 | 1 | 2004 | 2020 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
disease | 0.900 | strong | 0.953 | 2 | 2 | 1992 | 2020 | ||||||||
|
interferon regulatory factor 6 | 0.486 | 0.769 | 1.00 |
|
disease | 0.900 | None | 0.923 | 2 | 4 | 2003 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.900 | strong | 0.954 | 2 | 2 | 1995 | 2019 | ||||||||
|
lin-28 homolog B | 0.556 | 0.654 | 0.56 |
|
disease | 0.900 | None | 1.000 | 1 | 1 | 2012 | 2020 | ||||||||
|
C9orf72-SMCR8 complex subunit | 0.496 | 0.769 | 1.1E-06 |
|
disease | 0.800 | limited | 0.985 | 5 | 13 | 2009 | 2020 | ||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
disease | 0.800 | None | 0.978 | 5 | 5 | 1998 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
disease | 0.800 | disputed | 0.929 | 1 | 12 | 1998 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | None | 0.833 | 1 | 1 | 2007 | 2018 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.965 | 25 | 9 | 2006 | 2020 | ||||||||
|
CDK5 regulatory subunit associated protein 1 like 1 | 0.617 | 0.615 | 1.6E-02 |
|
disease | 0.700 | None | 0.984 | 21 | 86 | 2007 | 2019 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.950 | 13 | 19 | 2006 | 2020 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.700 | None | 0.983 | 11 | 32 | 1997 | 2020 | ||||||||
|
age-related maculopathy susceptibility 2 | 0.670 | 0.308 | 5.2E-04 |
|
disease | 0.700 | limited | 0.951 | 10 | 3 | 2005 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.942 | 9 | 11 | 1991 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.700 | None | 0.899 | 9 | 4 | 2004 | 2019 | ||||||||
|
autophagy related 16 like 1 | 0.543 | 0.769 | 0.96 |
|
disease | 0.700 | None | 0.953 | 8 | 5 | 2001 | 2020 |